Healthpeak Properties

DOC Real Estate Market cap $14.0B as of Sep 14, 2026 16:00 ET S&P 500

Q2 FY26 Apr 1 – Jun 30, 2026 reported Aug 5, 2026

Revenue$0.77B +11% year over year

Operating profit$0.03B 4% margin

Net profit$0.05B 7% margin

Net profit is larger than what operations earned, because the statement adds $0.02B below it, under Other income, net.

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	0.77	100%	+11%
Outpatient medical	0.31	40%
Senior housing	0.22	28%
Lab	0.22	28%
Other revenue	0.03	4%
Operating expenses	−0.74	96%
Property operating	−0.33	43%
Interest	−0.09	12%
G&A	−0.02	3%	+0pp
Other	−0.29	38%
Operating profit	0.03	4% margin	−2pp
Other income, net	0.02
Net profit	0.05	7% margin	+2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	0.75	100%	+7%
Outpatient medical	0.32	42%
Lab	0.21	28%
Senior housing	0.20	27%
Other revenue	0.02	3%
Operating expenses	−0.75	99%
Property operating	−0.32	43%
Interest	−0.09	12%
G&A	−0.03	3%	+0pp
Other	−0.31	41%
Operating profit	0.01	1% margin	−8pp
Other income, net	0.19
Net profit	0.19	26% margin	+20pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.72	100%	+3%
Operating expenses	−0.66	92%
Interest	−0.08	11%	+1pp
G&A	−0.02	4%	+0pp
Other	−0.56	77%	+0pp
Operating profit	0.06	8% margin	+4pp
Other income, net	0.06
Tax	−0.01
Net profit	0.11	16% margin	+15pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.71	100%	+1%
Outpatient medical	0.33	47%	+3%
Lab	0.21	30%	−5%
CCRC	0.15	21%	+5%
Other revenue	0.02	2%
Cost of revenue	−0.29	41%
Gross profit	0.41	59% margin	−1pp
G&A	−0.02	3%	+0pp
Other	−0.34	48%
Operating profit	0.05	7% margin	+2pp
Interest & other costs	−0.17
Net profit	−0.12	−17% margin	−29pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.69	100%	+0%
Outpatient medical	0.32	46%
Lab	0.21	30%
CCRC	0.15	22%
Other revenue	0.02	2%
Cost of revenue	−0.28	40%
Gross profit	0.42	60% margin	+0pp
G&A	−0.02	3%	−1pp
Other	−0.35	51%	+0pp
Operating profit	0.04	6% margin	+2pp
Interest & other costs	−0.01
Net profit	0.03	5% margin	−16pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY25 (period ends Mar 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.70	100%	+16%
Outpatient medical	0.32	46%
Lab	0.22	31%
CCRC	0.15	21%
Other revenue	0.02	2%
Cost of revenue	−0.27	39%
Gross profit	0.43	61% margin	+1pp
G&A	−0.03	3%	+0pp
Other	−0.34	49%	+0pp
Operating profit	0.06	9% margin	+18pp
Interest & other costs	−0.02
Net profit	0.04	6% margin	+5pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Sep 30, 2024).
Item	Value	Share of revenue	Year over year
Revenue	0.70	100%	+26%
Outpatient medical	0.32	46%
Lab	0.23	32%
CCRC	0.14	20%
Other revenue	0.01	2%
Cost of revenue	−0.28	40%
Gross profit	0.42	60% margin	+2pp
G&A	−0.02	3%	−1pp
Other	−0.36	52%	+0pp
Operating profit	0.04	5% margin	−7pp
Other income, net	0.05
Net profit	0.09	12% margin	+1pp

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26 Apr 1 – Jun 30, 2026 reported Aug 5, 2026 Operating margin 4% Net profit $0.05B	Apr 1 – Jun 30, 2026	Aug 5, 2026	$0.77B	+11%	4%	$0.05B	7%
Q1 FY26 Jan 1 – Mar 31, 2026 reported May 6, 2026 Operating margin 1% Net profit $0.19B	Jan 1 – Mar 31, 2026	May 6, 2026	$0.75B	+7%	1%	$0.19B	26%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 3, 2026 Operating margin 8% Net profit $0.11B	Oct 1 – Dec 31, 2025	Feb 3, 2026	$0.72B	+3%	8%	$0.11B	16%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Oct 24, 2025 Operating margin 7% Net profit −$0.12B	Jul 1 – Sep 30, 2025	Oct 24, 2025	$0.71B	+1%	7%	−$0.12B	−17%
Q2 FY25 Apr 1 – Jun 30, 2025 reported Jul 25, 2025 Operating margin 6% Net profit $0.03B	Apr 1 – Jun 30, 2025	Jul 25, 2025	$0.69B	+0%	6%	$0.03B	5%
Q1 FY25 Jan 1 – Mar 31, 2025 reported Apr 25, 2025 Operating margin 9% Net profit $0.04B	Jan 1 – Mar 31, 2025	Apr 25, 2025	$0.70B	+16%	9%	$0.04B	6%
Q3 FY24 Jul 1 – Sep 30, 2024 reported Oct 25, 2024 Operating margin 5% Net profit $0.09B	Jul 1 – Sep 30, 2024	Oct 25, 2024	$0.70B	+26%	5%	$0.09B	12%